Scientists Uncover Over 1,700 'Dark' Proteins in Human Cells, Potentially Transforming Disease Therapies
A groundbreaking study has identified over 1,700 'dark' proteins within the human genome, challenging previous assumptions about DNA functionality. These proteins, termed 'peptideins', are produced from parts of the genome traditionally considered non-coding or 'junk' DNA. The research, conducted by an international team, utilized advanced techniques to reveal these proteins, which are smaller and differ from conventional proteins. The study involved analyzing 3.7 billion data points from 95,520 experiments, leading to the identification of 1,785 microproteins. One such protein, derived from the OLMALINC gene, has shown potential in cancer survival, as its deactivation in lab tests hindered cancer cell growth. This discovery suggests that these peptideins could play significant roles in future disease therapies.